About this trial
Obessive-Compulsive Disorder (OCD) is frequently treatment-refractory and imposes a substantial burden on affected individuals. Although Exposure and Response Prevention (ERP) is widely regarded as the first-line intervention, its inherently distressing nature contributes to treatment refusal and premature dropout in a subset of patients. The present study aims to develop and validate a novel intervention, Mindfulness-Based Exposure Therapy (MBET).
In contrast to existing protocols that incorporate mindfulness as an adjunct to ERP and have yielded mixed or limited benefits, this study seeks a theoretically grounded integration of mindfulness and exposure-based principles. We hypothesize that mindfulness training improves emotion regulation, thereby producing a synergistic effect that enhances patients' capacity to engage in and complete exposure tasks.
From a clinical perspective, MBET is intended to offer a more tolerable and acceptable alternative to standard ERP, with the potential to improve treatment adherence and clinical outcomes among patients who experience traditional exposure procedures as excessively distressing.
Eligibility criteria
Qualifiers
Have a primary diagnosis of Obsessive-Compulsive Disorder (OCD) according to DSM-5 criteria
Are between 16 and 55 years of age (inclusive)
Have a Yale-Brown Obsessive Compulsive Scale (Y-BOCS) total score ≥ 16
Have an education level of junior high school or above
Disqualifiers
Meet DSM-5 criteria for any other psychiatric disorder besides OCD
Have severe OCD symptoms that prevent completion of assessments
Exhibit active suicidal ideation or high suicide risk
Have a serious somatic disease, central nervous system disease, or substance abuse history
Trial design
Treatments tested in this trial
- mindfulness based exposure therapy
- Treatment as Usual (TAU)